tiprankstipranks
Orthofix Medical (DE:OM2)
FRANKFURT:OM2
Germany Market
OM2
Orthofix Medical
RESEARCH TOOLSreports

Orthofix Medical (OM2) Ratios

0 Followers

Orthofix Medical Ratios

DE:OM2's free cash flow for Q2 2026 was $0.71. For the 2026 fiscal year, DE:OM2's free cash flow was decreased by $ and operating cash flow was $-0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.84 2.45 2.57 2.54 3.06
Quick Ratio
 1.67 2.24 1.45 1.20 1.86
Cash Ratio
 0.66 0.48 0.49 0.20 0.61
Solvency Ratio
 0.19 -0.10 -0.17 -0.28 0.10
Operating Cash Flow Ratio
 0.11 0.20 0.15 -0.28 -0.14
Short-Term Operating Cash Flow Coverage
 0.00 8.37 0.00 -36.60 0.00
Net Current Asset Value
$ 2.29M$ 16.24M$ 43.12M$ 93.86M$ 134.22M
Leverage Ratios
Debt-to-Assets Ratio
 0.27 0.27 0.20 0.13 0.05
Debt-to-Equity Ratio
 0.55 0.51 0.36 0.20 0.06
Debt-to-Capital Ratio
 0.35 0.34 0.26 0.16 0.06
Long-Term Debt-to-Capital Ratio
 0.34 0.29 0.24 0.13 0.00
Financial Leverage Ratio
 2.03 1.89 1.78 1.55 1.36
Debt Service Coverage Ratio
 5.09 -1.11 -1.23 -8.32 10.57
Interest Coverage Ratio
 -1.22 -3.92 -2.86 -16.12 -10.30
Debt to Market Cap
 0.61 0.31 0.24 0.19 0.00
Interest Debt Per Share
 6.24 6.19 5.49 3.42 1.14
Net Debt to EBITDA
 1.22 -6.59 -2.82 -1.06 -1.86
Profitability Margins
Gross Profit Margin
69.59%67.09%68.28%65.13%73.18%
EBIT Margin
-4.55%-8.92%-11.79%-18.76%-3.56%
EBITDA Margin
12.86%-2.72%-4.28%-10.65%3.40%
Operating Profit Margin
-3.05%-8.33%-10.58%-18.63%-2.88%
Pretax Profit Margin
-7.24%-11.04%-15.49%-19.91%-3.84%
Net Profit Margin
-7.41%-11.21%-15.76%-20.28%-4.29%
Continuous Operations Profit Margin
-7.41%-11.21%-15.76%-20.28%-4.29%
Net Income Per EBT
102.39%101.52%101.71%101.83%111.54%
EBT Per EBIT
237.20%132.63%146.39%106.88%133.45%
Return on Assets (ROA)
-7.07%-10.84%-14.10%-16.36%-4.31%
Return on Equity (ROE)
-14.05%-20.49%-25.04%-25.29%-5.86%
Return on Capital Employed (ROCE)
-3.55%-10.07%-11.68%-18.30%-3.54%
Return on Invested Capital (ROIC)
-3.55%-10.01%-11.60%-18.17%-3.52%
Return on Tangible Assets
-10.08%-15.81%-21.02%-24.70%-5.81%
Earnings Yield
-16.90%-15.25%-18.92%-30.58%-4.79%
Efficiency Ratios
Receivables Turnover
 6.13 6.06 5.93 5.83 5.56
Payables Turnover
 3.99 4.63 5.20 4.46 4.48
Inventory Turnover
 1.37 7.92 1.34 1.17 1.23
Fixed Asset Turnover
 6.37 -74.16 5.72 4.69 7.91
Asset Turnover
 0.95 0.97 0.89 0.81 1.00
Working Capital Turnover Ratio
 2.83 3.22 3.08 3.49 2.74
Cash Conversion Cycle
 233.72 27.58 263.93 292.26 279.99
Days of Sales Outstanding
 59.50 60.25 61.50 62.62 65.64
Days of Inventory Outstanding
 265.74 46.09 272.67 311.45 295.88
Days of Payables Outstanding
 91.52 78.76 70.24 81.81 81.54
Operating Cycle
 325.24 106.34 334.17 374.07 361.53
Cash Flow Ratios
Operating Cash Flow Per Share
 0.42 0.84 0.68 -1.25 -0.57
Free Cash Flow Per Share
 -0.66 -0.03 -0.24 -2.94 -1.73
CapEx Per Share
 1.08 0.87 0.91 1.69 1.15
Free Cash Flow to Operating Cash Flow
 -1.59 -0.04 -0.35 2.36 3.01
Dividend Paid and CapEx Coverage Ratio
 0.39 0.96 0.74 -0.74 -0.50
Capital Expenditure Coverage Ratio
 0.39 0.96 0.74 -0.74 -0.50
Operating Cash Flow Coverage Ratio
 0.07 0.15 0.14 -0.39 -0.54
Operating Cash Flow to Sales Ratio
 0.02 0.04 0.03 -0.06 -0.03
Free Cash Flow Yield
-7.49%-0.21%-1.36%-21.77%-8.41%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -5.82 -6.65 -5.29 -3.27 -20.89
Price-to-Sales (P/S) Ratio
 0.43 0.74 0.83 0.66 0.90
Price-to-Book (P/B) Ratio
 0.85 1.34 1.32 0.83 1.22
Price-to-Free Cash Flow (P/FCF) Ratio
 -13.35 -472.73 -73.28 -4.59 -11.89
Price-to-Operating Cash Flow Ratio
 21.43 18.13 25.82 -10.82 -35.76
Price-to-Earnings Growth (PEG) Ratio
 -0.08 0.22 0.27 -0.01 0.42
Price-to-Fair Value
 0.85 1.34 1.32 0.83 1.22
Enterprise Value Multiple
 4.59 -33.64 -22.30 -7.29 24.49
Enterprise Value
 491.77M 751.86M 762.21M 579.08M 383.48M
EV to EBITDA
 4.59 -33.64 -22.30 -7.29 24.49
EV to Sales
 0.59 0.91 0.95 0.78 0.83
EV to Free Cash Flow
 -18.19 -587.85 -83.89 -5.37 -11.05
EV to Operating Cash Flow
 28.84 22.55 29.55 -12.66 -33.24
Tangible Book Value Per Share
 4.11 4.57 5.49 7.80 10.85
Shareholders’ Equity Per Share
 10.49 11.28 13.19 16.30 16.76
Tax and Other Ratios
Effective Tax Rate
 -0.02 -0.02 -0.02 -0.02 -0.12
Revenue Per Share
 20.37 20.62 20.97 20.33 22.92
Net Income Per Share
 -1.51 -2.31 -3.30 -4.12 -0.98
Tax Burden
 1.02 1.02 1.02 1.02 1.12
Interest Burden
 1.59 1.24 1.31 1.06 1.08
Research & Development to Revenue
 0.07 0.07 0.09 0.11 0.11
SG&A to Revenue
 0.50 0.56 0.67 0.19 0.17
Stock-Based Compensation to Revenue
 0.05 0.03 0.04 0.05 0.04
Income Quality
 -0.09 -0.36 -0.20 0.30 0.58
Currency in USD